Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
Proactive Investors Australia
Home
Proactive Investors Australia
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid have discovered new research that shows Midkine antibody restores bone less
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid’s Maria Halasz outlines revenue growth path at spotlight CEO session
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid Limited to enter the world’s largest hair loss treatment market
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid Completes world first study accelerating bone healing
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid Launches hair product range in Australia to drive revenue
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid Delivers record sales revenue in Japan
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid to benefit from data at Budapest Midkine Symposium
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid progresses on road to commercialize Midkine protein assets
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid Limited continues growth in Japan, set for sales increase
Prev page
1
2
3
4
5
6
7
8
9
Next page
